Publications by authors named "Xiaotang Zhou"

Article Synopsis
  • Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) is being replaced by bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) for HIV treatment due to better pharmacokinetics and fewer drug interactions, but its impact on lipid profiles is unclear.
  • In a study, HIV patients were monitored for 24 weeks after switching from E/C/F/TAF to B/F/TAF, with lipidomic analysis conducted at set intervals.
  • Results showed that those on B/F/TAF had significantly lower triglyceride and very low-density lipoprotein cholesterol levels, along with a slight improvement in cardiovascular
View Article and Find Full Text PDF

Weed control is a global issue of great concern, and smart weeding robots equipped with advanced vision algorithms can perform efficient and precise weed control. Furthermore, the application of smart weeding robots has great potential for building environmentally friendly agriculture and saving human and material resources. However, most networks used in intelligent weeding robots tend to solely prioritize enhancing segmentation accuracy, disregarding the hardware constraints of embedded devices.

View Article and Find Full Text PDF

Background: To evaluate the value and challenges of real-world clinical application of metagenomic next-generation sequencing (mNGS) for bronchoalveolar lavage fluid (BALF) in HIV-infected patients with suspected multi-pathogenic pneumonia.

Methods: Fifty-seven HIV-infected patients with suspected mixed pneumonia who were agreed to undergo the bronchoscopy were recruited and retrospectively reviewed the results of mNGS and conventional microbiological tests (CMTs) of BALF from July 2020 to June 2022.

Results: 54 patients were diagnosed with pneumonia including 49 patients with definite pathogens and five patients with probable pathogens.

View Article and Find Full Text PDF

Background: Hemophagocytic lymphohistiocytosis (HLH) is a fatal immunological syndrome resulting from excessive production of inflammatory cytokines. The conventional therapies for HLH, which are based on cytotoxic agents, are not always efficacious and safe, especially in patients with severe immunodeficiency. Ruxolitinib, a strong inhibitor of Janus kinase (JAK) 1/2, has already been evaluated as salvage and first-line therapy for HLH.

View Article and Find Full Text PDF

Background/aims: Patients with hepatitis B virus (HBV) infection are at a high risk of developing hepatocellular carcinoma (HCC). In this study, we aim to investigate the roles of HBV on angiogenin (ANG), as well as the effects on cell proliferation in presence of ANG down-regulation.

Methods: Serum ANG was determined by ELISA.

View Article and Find Full Text PDF

MEAN (6-methoxyethylamino-numonafide) is a small molecule compound, and here, we report that it effectively inhibits hepatitis C virus (HCV) infection in an HCV cell culture system using a JC1-Luc chimeric virus, with a 50% effective concentration (EC50) of 2.36 ± 0.29 μM.

View Article and Find Full Text PDF

Background: Lipocalin 2 (LCN2), a protein primarily produced by hepatocytes, is highly upregulated under various conditions that induce cellular stress, such as intoxication, infection or inflammation. However, the precise biological functions and underlying mechanisms of LCN2 in hepatocytes remains unknown.

Methods: Hepatocyte stress was successfully induced by treating Huh7 cells with interleukin-1β (IL-1β).

View Article and Find Full Text PDF

Background: Acute liver failure (ALF), known as a rapid and severe clinical syndrome, can induce multiple organ dysfunction and failure. It was noticed that Kupffer cells activation at the initial phase was involved in some intense inflammatory responses in the pathogenesis of ALF. However, detailed regulation mechanism of Kupffer cells activation during ALF is still obscured.

View Article and Find Full Text PDF

Self-microemulsifying drug delivery systems (SMEDDS) were developed to overcome the problems of delivery and administration of piroxicam, a drug with low bioavailability and gastrointestinal irritation, The in vitro properties of it were assessed. The solubility of piroxicam in several oils and surfactants was determined, and the compatibility of various oils and surfactants was investigated. Ternary phase diagrams were constructed to optimal area of microemulsion, and the influence of different oily phases, surfactants and co-surfactants was studied.

View Article and Find Full Text PDF